Table 1.

Description of visits

Visit	Pre-inclusion	Inclusion	Discovery or open titration			Treatment period (MPH or NFB)
			Initial discovery or titration	Discovery or titration	Discovery or titration	Final discovery or titration	Intermediate	Final
Day	D-90 to D-1	D0	D7 ± 3	D14 ± 3	D21 ± 3	D28 ± 3	D60 ± 7	D90 ± 10
Protocol explanation	X
Inform consent form		X
Inclusion/exclusion criteria		X
Demographic data		X
Medical/surgical history		X
Medical examination		X
qEEG		X					X	X
Randomisation		X
MPH delivery			X	X	X	X	X
NFB discovery session			X	X	X	X	X
Kiddie-Sads	X
ADHD RS parents		X					X	X
ADHD RS clinician		X					X	X
ADHD RS teacher		X						X
CGI-I score			X	X	X	X	X	X
CGI-S score		X	X	X	X	X	X	X
C-SSRS (Columbia suicide rating scale		X	X	X	X	X	X	X
SDSC		X	X	X	X	X	X	X
SDQ by teacher/parent		X						X
BRIEF		X						X
Conners 3 CPT		X						X
WASI 3 subtest (or WISC less 3 months)	X
Concomitant treatments		X	X	X	X	X	X	X
Adverse event collection (spontaneous)			X	X	X	X	X	X
PAERS questionnaire		X	X	X	X	X	X	X